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Background
Pancreatic metastases are rare, accounting for 2.8% of
cases in RCC, occurring as a result of haematogenous
spread to the pancreas. High affinity of some renal cancer
cells for the pancreatic parenchyma present solely as
isolated pancreatic metastases.
Literature reviews have highlighted that aggressive
surgery for isolated pancreatic metastasis has been shown
to increase 5 year survival rates unto 60%; particularly
nephrectomy & metastasectomy with adjuvant therapy.
The objective of this case study was to identify the
benefits of pancreas-preserving enucleation in treatment
of isolated pancreatic RCC metastases over traditional
pancreatic resections.
Report
Patient X was identified as a candidate for this case
report.
Mr X. is a 77 year old fit and healthy male, presented
with 2 day history of frank haematuria & weight loss of
3kg over 6 months with no associated fever, flank pain or
dysuria. CT KUB revealed lobulated soft tissue density in
the right kidney, suspicious for a tumour. Further staging
investigations of CT TAP demonstrated a small enhancing
nodule in pancreatic body confirmed as pancreatic metas-
tasis with EUA FNA. The patient subsequently underwent
Open Right Radical Nephrectomy with Enucleation of
Pancreatic Metastasis.
Discussion
Comparisons drawn between Pancreatic-sparing Enuclea-
tions and standard resection (Complete Pancreatectomy)
explore variations in surgical challenges & post-operative
complications. While there has been no difference in
morbidity and recurrence noted compared to complete
pancreatectomy; there has been significant reduction in
post-operative diabetes mellitus.
Conclusions
Pancreatic resections are associated with high rates of
morbidity and mortality. A reduction in operative risk fol-
lowing pancreatic surgery have been demonstrated, in
recent times. As such, Pancreas-sparing Enucleation &
Enucleo-resection has been considered a worthy option.
Preservation of pancreatic tissue allows for better quality
of life without diabetes mellitus.
Consent to publish
The patient had signed a written consent for publication
of this abstract on Pancreatic Metastases.
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